[Metformin for the treatment of polycystic ovary syndrome]

Publication

[Metformin for the treatment of polycystic ovary syndrome]

Journal Paper/Review - Feb 1, 2016

Gundelach Theresa, Rodewald Miriam, Bekes Inga, Janni Wolfgang, Hancke Katharina

Units

Brustzentrum St.Gallen, Medizinische Onkologie und Hämatologie

PubMed

26983336

Citation

Gundelach T, Rodewald M, Bekes I, Janni W, Hancke K. [Metformin for the treatment of polycystic ovary syndrome]. Med Monatsschr Pharm 2016; 39:75-8.

Type

Journal Paper/Review (Deutsch)

Journal

Med Monatsschr Pharm 2016; 39

Publication Date

Feb 1, 2016

Issn Print

0342-9601

Pages

75-8

Brief description/objective

For several years there is an evidence for a relationship between the polycystic ovary syndrome (PCOS) and of insulin resistance; therefore metformin, an insulin sensitizer, is used for the treatment for more than 10 years. However, the evidence for metformin is assessed controversially. This review will give an overview about the data published on this topic.